In this special ADA 2025 edition of Beyond the Bolus, host Nancy sits down with Kellee Miller and Jennifer Boyd from Insulet’s Medical Affairs team to discuss groundbreaking data on the Omnipod 5 Automated Insulin Delivery System in people with type 2 diabetes. From real-world evidence across 23,000+ users to insights on insulin dosing, quality of life, and optimized settings, this episode dives deep into how Omnipod 5 is transforming diabetes care. Whether you're a prescriber, educator, or caring for someone living with diabetes, this conversation offers valuable takeaways on the future of AID technology.

In this special ADA 2025 edition of Beyond the Bolus, host Nancy sits down with Kellee Miller and Jennifer Boyd from Insulet’s Medical Affairs team to discuss groundbreaking data on the Omnipod 5 Automated Insulin Delivery System in people with type 2 diabetes. From real-world evidence across 23,000+ users to insights on insulin dosing, quality of life, and optimized settings, this episode dives deep into how Omnipod 5 is transforming diabetes care. Whether you're a prescriber, educator, or caring for someone living with diabetes, this conversation offers valuable takeaways on the future of AID technology.

Beyond the Bolus

Real-world impact of Omnipod® 5 in type 2 diabetes (featuring. Kellee Miller & Jennifer Boyd)

How can AID systems like Omnipod 5 ease the mental burden on patients living with diabetes? To find out, Beyond the Bolus hosts Nancy Hanna and Dena Gottesman handed over hosting duties to our international colleague, Kate Neal, who was at ATTD in Amsterdam speaking with Dr. Eden Miller, a family practitioner, diabetologist, and co-founder of Diabetes Nation.  Dr. Miller shares her perspective (as both a healthcare provider and a person living with diabetes), explaining why she considers Omnipod 5 to be a “diabetes partner” – one that adapts and helps patients live more freely with less mental burden. They discuss how customizable glucose targets, setting adjustments, and the Custom Foods feature provide patients with a personalized and supportive experience. Kate and Dr. Miller take a closer look at the SECURE-T2D study, which evaluated the use of Omnipod 5 in adults with type 2 diabetes. Dr. Miller outlines the key results and reflects on how the findings are already transforming her clinical practice.  You’ll also hear stories from Dr. Miller’s practice, such as a 78-year-old patient who was recently diagnosed with type 1 diabetes, and a 9-year-old who is learning independence - and managing type 1 diabetes – with the help of the Custom Foods feature. Dr. Miller brings a practical, person-first approach to care, whether she’s breaking down barriers to technology, helping patients build confidence, or supporting them through the emotional side of diabetes.

How can AID systems like Omnipod 5 ease the mental burden on patients living with diabetes? To find out, Beyond the Bolus hosts Nancy Hanna and Dena Gottesman handed over hosting duties to our international colleague, Kate Neal, who was at ATTD in Amsterdam speaking with Dr. Eden Miller, a family practitioner, diabetologist, and co-founder of Diabetes Nation.  Dr. Miller shares her perspective (as both a healthcare provider and a person living with diabetes), explaining why she considers Omnipod 5 to be a “diabetes partner” – one that adapts and helps patients live more freely with less mental burden. They discuss how customizable glucose targets, setting adjustments, and the Custom Foods feature provide patients with a personalized and supportive experience. Kate and Dr. Miller take a closer look at the SECURE-T2D study, which evaluated the use of Omnipod 5 in adults with type 2 diabetes. Dr. Miller outlines the key results and reflects on how the findings are already transforming her clinical practice.  You’ll also hear stories from Dr. Miller’s practice, such as a 78-year-old patient who was recently diagnosed with type 1 diabetes, and a 9-year-old who is learning independence - and managing type 1 diabetes – with the help of the Custom Foods feature. Dr. Miller brings a practical, person-first approach to care, whether she’s breaking down barriers to technology, helping patients build confidence, or supporting them through the emotional side of diabetes.

Omnipod® 5 as your diabetes partner: support that adapts to you (featuring Dr. Eden Miller)

The guest on this episode has an ongoing commercial relationship with Insulet, and Insulet has paid a fee for their participation in this podcast.In this episode, we dive into the SECURE T2D publication, with Dr. Chris Bajaj, an author and investigator in this groundbreaking study. Featuring a diverse population of participants with type 2 diabetes, the study revealed significant A1C reduction1, especially for those participants with baseline A1C above 9%. We also explore the simplified bolus strategies used to support patients, including those not carb counting at the start of the study. Tune in to learn how this research is shaping real-world diabetes care for people living with type 2 diabetes! 1. Pasquel FJ, et al. JAMA Network Open (2025). Prospective pivotal trial in 305 participants with T2D aged 18-75 yrs. Study included a 14-day standard therapy (ST) phase followed by a 13-week Omnipod 5 hybrid closed-loop phase. In a subgroup analysis of 68 participants with baseline A1c ≥ 9% Mean HbA1c: ST vs. 13-week Omnipod 5: 10.1% vs. 8.1%; (95% CI: -2.3%, -1.9%)

The guest on this episode has an ongoing commercial relationship with Insulet, and Insulet has paid a fee for their participation in this podcast.In this episode, we dive into the SECURE T2D publication, with Dr. Chris Bajaj, an author and investigator in this groundbreaking study. Featuring a diverse population of participants with type 2 diabetes, the study revealed significant A1C reduction1, especially for those participants with baseline A1C above 9%. We also explore the simplified bolus strategies used to support patients, including those not carb counting at the start of the study. Tune in to learn how this research is shaping real-world diabetes care for people living with type 2 diabetes!1. Pasquel FJ, et al. JAMA Network Open (2025). Prospective pivotal trial in 305 participants with T2D aged 18-75 yrs. Study included a 14-day standard therapy (ST) phase followed by a 13-week Omnipod 5 hybrid closed-loop phase. In a subgroup analysis of 68 participants with baseline A1c ≥ 9% Mean HbA1c: ST vs. 13-week Omnipod 5: 10.1% vs. 8.1%; (95% CI: -2.3%, -1.9%)

Digging into the SECURE T2D publication data: diverse patients, powerful outcomes

The guest on this episode has an ongoing commercial relationship with Insulet, and Insulet has paid a fee for their participation in this podcast. In this Beyond the Bolus episode, Mark Heyman, PhD CDCES, shares his experience using the Omnipod 5 App for iPhone as part of the limited market release (LMR). Dr. Heyman discusses this system's new features and how these have benefited his mental well-being and reduced his diabetes distress. Dive in to hear how the Omnipod 5 App for iPhone could help enhance your patient's diabetes management!

The guest on this episode has an ongoing commercial relationship with Insulet, and Insulet has paid a fee for their participation in this podcast. In this Beyond the Bolus episode, Mark Heyman, PhD CDCES, shares his experience using the Omnipod 5 App for iPhone as part of the limited market release (LMR). Dr. Heyman discusses this system's new features and how these have benefited his mental well-being and reduced his diabetes distress. Dive in to hear how the Omnipod 5 App for iPhone could help enhance your patient's diabetes management! 

Mind Over Diabetes: A Psychologist’s Take on the Freedom of Omnipod® 5 for iPhone (featuring Mark Heyman, PhD CDCES)

The guest on this episode has an ongoing commercial relationship with Insulet, and Insulet has paid a fee for their participation in this podcast.Recorded Live at ADCES in New Orleans, Louisiana. In this episode, Jennifer Okemah joins us as we dive deep into SmartAdjust™ technology, the groundbreaking algorithm behind the Omnipod 5 Automated Insulin Delivery System. Jennifer breaks down how healthcare providers can fine-tune this innovative tool to better support patients with diabetes, ensuring more personalized insulin delivery to meet your patients’ individual needs. Discover actionable strategies to maximize the benefits of SmartAdjust™ technology, improve patient results, and enhance overall diabetes management. Whether you’re a seasoned clinician or new to the Omnipod 5, this discussion offers valuable insights to help you get the most out of this cutting-edge technology. Tune in for expert tips and practical guidance!

The guest on this episode has an ongoing commercial relationship with Insulet, and Insulet has paid a fee for their participation in this podcast.Recorded Live at ADCES in New Orleans, Louisiana. In this episode, Jennifer Okemah joins us as we dive deep into SmartAdjust™ technology, the groundbreaking algorithm behind the Omnipod 5 Automated Insulin Delivery System. Jennifer breaks down how healthcare providers can fine-tune this innovative tool to better support patients with diabetes, ensuring more personalized insulin delivery to meet your patients’ individual needs. Discover actionable strategies to maximize the benefits of SmartAdjust™ technology, improve patient results, and enhance overall diabetes management. Whether you’re a seasoned clinician or new to the Omnipod 5, this discussion offers valuable insights to help you get the most out of this cutting-edge technology. Tune in for expert tips and practical guidance!

Optimizing Omnipod® 5 for Better Patient Outcomes (featuring Jennifer Okemah MS, RDN, CSSD, BC-ADM, CDCES)

Recorded Live at ADCES in New Orleans, Louisiana. Dive into the groundbreaking SECURE T2D study, the largest and most diverse trial ever conducted on Automated Insulin Delivery (AID) for people with type 2 diabetes. Discover how Omnipod 5 demonstrated improvements in A1C levels, increased time in range (TIR), and participant-reported reduction in Diabetes Distress. Dr. Viral Shah from the Indiana University School of Medicine, and an investigator in this trial, reveals key insights on how Omnipod 5 can help simplify diabetes management. Don’t miss this chance to learn how Omnipod 5 can enhance your care for your patients living with type 2 diabetes. ------------ Dr. Viral Shah is an endocrinologist. Dr. Shah has an ongoing commercial relationship with Insulet and Insulet has paid him a fee to participate in this podcast. The opinions and views expressed in this podcast are his own.

Recorded Live at ADCES in New Orleans, Louisiana.Dive into the groundbreaking SECURE T2D study, the largest and most diverse trial ever conducted on Automated Insulin Delivery (AID) for people with type 2 diabetes.Discover how Omnipod 5 demonstrated improvements in A1C levels, increased time in range (TIR), and participant-reported reduction in Diabetes Distress. Dr. Viral Shah from the Indiana University School of Medicine, and an investigator in this trial, reveals key insights on how Omnipod 5 can help simplify diabetes management.Don’t miss this chance to learn how Omnipod 5 can enhance your care for your patients living with type 2 diabetes.------------Dr. Viral Shah is an endocrinologist. Dr. Shah has an ongoing commercial relationship with Insulet and Insulet has paid him a fee to participate in this podcast. The opinions and views expressed in this podcast are his own.

Unlock the Future of Type 2 Diabetes Care with Dr. Viral Shah

Recorded live at the ADA Conference in Orlando, Florida. Dive into the future of diabetes management with Eric Benjamin, Insulet’s Chief Product & Customer Experience Officer. In this episode, Eric reveals the innovative journey behind Omnipod, highlighting our relentless focus on customer needs and top-tier performance with every Pod change. Discover how we're revolutionizing Automated Insulin Delivery with our wearable, tubeless Pod, and learn how these advancements simplify life for people with diabetes. Don't miss this insider's perspective on transforming care through cutting-edge technology. ------------ Eric Benjamin is an employee of Insulet Corporation. The opinions shared in the podcast are his own.

Recorded live at the ADA Conference in Orlando, Florida.Dive into the future of diabetes management with Eric Benjamin, Insulet’s Chief Product & Customer Experience Officer. In this episode, Eric reveals the innovative journey behind Omnipod, highlighting our relentless focus on customer needs and top-tier performance with every Pod change. Discover how we're revolutionizing Automated Insulin Delivery with our wearable, tubeless Pod, and learn how these advancements simplify life for people with diabetes. Don't miss this insider's perspective on transforming care through cutting-edge technology.------------Eric Benjamin is an employee of Insulet Corporation. The opinions shared in the podcast are his own.

The Power of the Pod

Recorded live at the ADA Conference in Orlando, Florida. Nancy Hanna is joined by Dr. Pablo Mora who is an Endocrinologist at the North Texas Diabetes & Endocrinology Medical Center in Plano, Texas. During this episode, Nancy and Dr. Mora discuss the integration between the Omnipod 5 Automated Insulin Delivery System and the Dexcom G7 CGM. Dr. Mora discusses his experience as part of the Limited Market Release for Omnipod 5 with Dexcom G7 and provides insights into the benefit of this integration for his patients with type 1 diabetes. Listen to learn how Dr. Mora has leveraged this technology to simplify diabetes management with his patients! ------------Dr. Pablo Mora is an endocrinologist. Dr. Mora has an ongoing commercial relationship with Insulet and Insulet has paid him a fee to participate in this podcast. The opinions and views expressed in this podcast are his own.

Recorded live at the ADA Conference in Orlando, Florida. Nancy Hanna is joined by Dr. Pablo Mora who is an Endocrinologist at the North Texas Diabetes & Endocrinology Medical Center in Plano, Texas. During this episode, Nancy and Dr. Mora discuss the integration between the Omnipod 5 Automated Insulin Delivery System and the Dexcom G7 CGM. Dr. Mora discusses his experience as part of the Limited Market Release for Omnipod 5 with Dexcom G7 and provides insights into the benefit of this integration for his patients with type 1 diabetes. Listen to learn how Dr. Mora has leveraged this technology to simplify diabetes management with his patients! ------------Dr. Pablo Mora is an endocrinologist. Dr. Mora has an ongoing commercial relationship with Insulet and Insulet has paid him a fee to participate in this podcast. The opinions and views expressed in this podcast are his own.

Omnipod 5 with Dexcom G7 Integration is Here!

Recorded live at the ADA Conference in Orlando, Florida 2024.Nancy Hanna is joined by Cari Berget MPH, RN, CDCES who is a Research Instructor of Pediatric Endocrinology at the University of Colorado School of Medicine – Barbara Davis Center. During this episode, Nancy and Cari discuss automated insulin delivery (AID) candidacy and challenge the perception that people need to meet certain requirements to be considered for AID. Cari shares her experience prescribing diabetes technology to patients who typically might not been considered for automated insulin delivery and shows the progress and clinical benefits that some of her patients have experienced on Omnipod 5.  ------------Cari Berget, MPH is a Registered Nurse (RN) and a Certified Diabetes Care and Education Specialist (CDCES). Cari Berget has an ongoing commercial relationship with Insulet and Insulet has paid her a fee to participate in this podcast. The opinions and views expressed in this podcast are her own.

Recorded live at the ADA Conference in Orlando, Florida 2024.Nancy Hanna is joined by Cari Berget MPH, RN, CDCES who is a Research Instructor of Pediatric Endocrinology at the University of Colorado School of Medicine – Barbara Davis Center. During this episode, Nancy and Cari discuss automated insulin delivery (AID) candidacy and challenge the perception that people need to meet certain requirements to be considered for AID. Cari shares her experience prescribing diabetes technology to patients who typically might not been considered for automated insulin delivery and shows the progress and clinical benefits that some of her patients have experienced on Omnipod 5.  ------------Cari Berget, MPH is a Registered Nurse (RN) and a Certified Diabetes Care and Education Specialist (CDCES). Cari Berget has an ongoing commercial relationship with Insulet and Insulet has paid her a fee to participate in this podcast. The opinions and views expressed in this podcast are her own.

Challenging AID Candidacy Norms

Recorded live at the ADA Conference in Orlando, Florida. Nancy Hanna is joined by Dr. Greg Forlenza who is an Endocrinologist at the University of Colorado School of Medicine – Barbara Davis Center. Dr. Forlenza is the lead author of a publication in the Diabetes Technology & Therapeutics in which the use of the Omnipod 5 Automated Insulin Delivery System was analyzed in almost 70,000 people with type 1 diabetes. Nancy and Dr. Forlenza discuss the relevance of real-world evidence from a diverse group of patients and how that translates into actual practice. Learn how Omnipod 5 has performed in real-world settings, and why having this data can help personalize diabetes care by understanding how different patient demographics can benefit from tubeless AID technology.  ------------ Dr. Greg Forlenza is an endocrinologist. Dr. Forlenza has an ongoing commercial relationship with Insulet and Insulet has paid him a fee to participate in this podcast. The opinions and views expressed in this podcast are his own.

Recorded live at the ADA Conference in Orlando, Florida.Nancy Hanna is joined by Dr. Greg Forlenza who is an Endocrinologist at the University of Colorado School of Medicine – Barbara Davis Center. Dr. Forlenza is the lead author of a publication in the Diabetes Technology & Therapeutics in which the use of the Omnipod 5 Automated Insulin Delivery System was analyzed in almost 70,000 people with type 1 diabetes.Nancy and Dr. Forlenza discuss the relevance of real-world evidence from a diverse group of patients and how that translates into actual practice. Learn how Omnipod 5 has performed in real-world settings, and why having this data can help personalize diabetes care by understanding how different patient demographics can benefit from tubeless AID technology. ------------Dr. Greg Forlenza is an endocrinologist. Dr. Forlenza has an ongoing commercial relationship with Insulet and Insulet has paid him a fee to participate in this podcast. The opinions and views expressed in this podcast are his own.

Omnipod 5 Real-World Evidence Data: A Deep Dive

<div>Recorded live at the ADCES Conference in Houston, Nancy Hanna and Dena Gottesman are joined by Dr. William Polonsky. Dr. Polonsky is the founder and president of the Behavioral Diabetes Institute, an organization dedicated to studying the unmet psychological needs of people living with diabetes. He’s also an Associate Clinical Professor at the University of California in San Diego.  Highlights include: • Where to find the best lactose-free ice cream in the universe! • Dr. Polonsky’s golden nugget for new diabetes educators.  • The one question you should ask all your patients at every visit.  • How the world’s first behavioral diabetes institute was formed.  • The origin and meaning of the term “Diabetes Distress” and strategies to communicate effectively with patients and ease burden • Psychosocial outcomes with Omnipod 5 and impact on caregivers  Dr. William Polonsky has an ongoing commercial relationship with Insulet and Insulet has paid him a fee to participate in the making of this podcast. The opinions and views expressed in this podcast are his own. Please speak with your Healthcare team before making any changes to your diabetes management. This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution. **Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information. </div>

Recorded live at the ADCES Conference in Houston, Nancy Hanna and Dena Gottesman are joined by Dr. William Polonsky. Dr. Polonsky is the founder and president of the Behavioral Diabetes Institute, an organization dedicated to studying the unmet psychological needs of people living with diabetes. He’s also an Associate Clinical Professor at the University of California in San Diego. Highlights include:• Where to find the best lactose-free ice cream in the universe!• Dr. Polonsky’s golden nugget for new diabetes educators. • The one question you should ask all your patients at every visit. • How the world’s first behavioral diabetes institute was formed. • The origin and meaning of the term “Diabetes Distress” and strategies to communicate effectively with patients and ease burden• Psychosocial outcomes with Omnipod 5 and impact on caregivers Dr. William Polonsky has an ongoing commercial relationship with Insulet and Insulet has paid him a fee to participate in the making of this podcast. The opinions and views expressed in this podcast are his own.Please speak with your Healthcare team before making any changes to your diabetes management. This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution. **Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information.

Diabetes Distress with Dr. William Polonsky

<div>This special episode is a compilation of conversations from the Association of Diabetes Care & Education Specialists (ADCES) 2023 conference in Houston.  Joining Nancy on day 2 of the conference were a few very special guests. Alissa Heizler-Mendoza, a registered dietitian and certified diabetes care and education specialist dropped by the studio to discuss her role of leading the advocacy and government affairs team at Insulet. She empowers us to elevate our voices to influence change and help more people living with diabetes access life-changing technology. Sarah Yourman-Tota also stopped by to chat with Nancy about her work in pediatric endocrinology, and the positive impact technology can have for caregivers.    Nancy was also joined by Jennifer Boyd, medical science liaison at Insulet. Jenn discusses some patient success stories from one year of Omnipod 5. Lastly, Nancy and Dena are joined by Dr. Diana Isaacs and Natalie Bellini to discuss common misconceptions people have about different AID systems. Diana Isaacs and Natalie Bellini have an ongoing commercial relationship with Insulet. Each guest’s views and opinions are their own and not those of Insulet. Please speak with your Healthcare team before making any changes to your diabetes management. This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution. **Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information.</div>

This special episode is a compilation of conversations from the Association of Diabetes Care & Education Specialists (ADCES) 2023 conference in Houston. Joining Nancy on day 2 of the conference were a few very special guests. Alissa Heizler-Mendoza, a registered dietitian and certified diabetes care and education specialist dropped by the studio to discuss her role of leading the advocacy and government affairs team at Insulet. She empowers us to elevate our voices to influence change and help more people living with diabetes access life-changing technology.Sarah Yourman-Tota also stopped by to chat with Nancy about her work in pediatric endocrinology, and the positive impact technology can have for caregivers.   Nancy was also joined by Jennifer Boyd, medical science liaison at Insulet. Jenn discusses some patient success stories from one year of Omnipod 5.Lastly, Nancy and Dena are joined by Dr. Diana Isaacs and Natalie Bellini to discuss common misconceptions people have about different AID systems. Diana Isaacs and Natalie Bellini have an ongoing commercial relationship with Insulet.Each guest’s views and opinions are their own and not those of Insulet.Please speak with your Healthcare team before making any changes to your diabetes management. This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution. **Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information.

Celebrating 50 years of Advancing Diabetes Care & Education

<div>Join us for an insightful journey into the world of diabetes management technology on this very special episode of Beyond The Bolus. Recorded live from the American Diabetes Association’s 83rd Scientific Sessions in San Diego, host Nancy Hanna is joined by Dexcom’s Cher Pastore in our very first simulcast. </div><div> </div><div>To explore how Omnipod and Dexcom are influencing the dynamics of diabetes technology and reshaping patient outcomes for the better, they’re joined by Dr. Viral Shah - an endocrinologist whose research into these innovative therapies has touched and improved countless lives.</div><div> </div><div>During the episode, you'll discover how technological advancements are changing the game and reducing daily management burdens for people with diabetes. Hear invaluable insights from Dr. Shah on the importance of early adoption of tools such as CGM and the Omnipod 5, and how they can prove pivotal in managing diabetes and improving glycemic control. </div><div>Dr. Shah examines the different barriers to technology adoption, and how fostering a pro-active conversation can help overcome them. All this, plus a sneak peek into the future of diabetes tech. Please speak with your Healthcare team before making any changes to your diabetes management.  This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution.  **Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information. Cited resources: 1 Champakanath A, et al. Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study. Diabetes Care. 2022;45(3):750-753.</div><div>2 Brown SA, et al. Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes. Diabetes Care. 2021;44(7):1630-1640.</div>

Join us for an insightful journey into the world of diabetes management technology on this very special episode of Beyond The Bolus. Recorded live from the American Diabetes Association’s 83rd Scientific Sessions in San Diego, host Nancy Hanna is joined by Dexcom’s Cher Pastore in our very first simulcast.  To explore how Omnipod and Dexcom are influencing the dynamics of diabetes technology and reshaping patient outcomes for the better, they’re joined by Dr. Viral Shah - an endocrinologist whose research into these innovative therapies has touched and improved countless lives. During the episode, you'll discover how technological advancements are changing the game and reducing daily management burdens for people with diabetes. Hear invaluable insights from Dr. Shah on the importance of early adoption of tools such as CGM and the Omnipod 5, and how they can prove pivotal in managing diabetes and improving glycemic control. Dr. Shah examines the different barriers to technology adoption, and how fostering a pro-active conversation can help overcome them. All this, plus a sneak peek into the future of diabetes tech.Please speak with your Healthcare team before making any changes to your diabetes management.  This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution.  **Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information. Cited resources:1 Champakanath A, et al. Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study. Diabetes Care. 2022;45(3):750-753.2 Brown SA, et al. Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes. Diabetes Care. 2021;44(7):1630-1640.

A Dynamic Duo: Omnipod & Dexcom

<div>Insulet and Beyond The Bolus are back at the ADA Scientific Sessions. Nancy Hanna, Clinical Services Manager at Insulet, is joined by Dr. Anita Swamy for a special live podcast, recording at the Omnipod booth in San Diego.  Join them on a truly enlightening journey into the world of diabetes management as seen through the lens of the latest technology. The Omnipod 5 system offers an optimistic approach towards alleviating the daily challenges associated with managing diabetes.    Dr. Swamy is a stalwart in diabetes management, and she delivers a masterclass for the listeners on integrating technology into patient care. Dr. Swamy presents in-depth knowledge of both types of diabetes and their unique needs. She pinpoints how innovative methods such as the Automated Insulin Delivery (AID) can result in a marked improvement in patient care while minimizing disease management-associated stress.  Furthermore, the episode addresses low-resource demographics' ability to utilize such technology, breaking common misconceptions. Additionally, with a keen focus on patients transitioning from pediatrics to adult care, Dr. Swamy shares strategies to empower these patients in managing their disease independently. Please speak with your Healthcare team before making any changes to your diabetes management.  This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution.  **Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information.</div>

Insulet and Beyond The Bolus are back at the ADA Scientific Sessions. Nancy Hanna, Clinical Services Manager at Insulet, is joined by Dr. Anita Swamy for a special live podcast, recording at the Omnipod booth in San Diego. Join them on a truly enlightening journey into the world of diabetes management as seen through the lens of the latest technology. The Omnipod 5 system offers an optimistic approach towards alleviating the daily challenges associated with managing diabetes.  Dr. Swamy is a stalwart in diabetes management, and she delivers a masterclass for the listeners on integrating technology into patient care.Dr. Swamy presents in-depth knowledge of both types of diabetes and their unique needs. She pinpoints how innovative methods such as the Automated Insulin Delivery (AID) can result in a marked improvement in patient care while minimizing disease management-associated stress. Furthermore, the episode addresses low-resource demographics' ability to utilize such technology, breaking common misconceptions. Additionally, with a keen focus on patients transitioning from pediatrics to adult care, Dr. Swamy shares strategies to empower these patients in managing their disease independently.Please speak with your Healthcare team before making any changes to your diabetes management. This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution. **Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information.

Teenage Transitions

<div>Nancy Hanna RN, BSN, CDCES and Dena Gottesman MS, RD, CDCES are joined by Leslie Barrett MS, RD, CDCES to clear up common misconceptions about the Omnipod® 5 Automated Insulin Delivery System. Leslie has been working on Omnipod® 5 since the development from user experience and design to clinical trial site training and support. In part 2 of this fact from fake news episode she will share more details on the Omnipod 5 algorithm known as SmartAdjust™ technology and best practices for everyday use and optimization.  Questions covered in this episode: • What are the requirements for entering Automated Mode? • What are the considerations for transitioning from different therapies? • How often should users deliver correction boluses? • What are the adjustable settings for Omnipod 5, and what does and does not impact algorithm behavior?   Please speak with your healthcare team before making any changes to your diabetes management. This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution.  **Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information. </div>

Nancy Hanna RN, BSN, CDCES and Dena Gottesman MS, RD, CDCES are joined by Leslie Barrett MS, RD, CDCES to clear up common misconceptions about the Omnipod® 5 Automated Insulin Delivery System. Leslie has been working on Omnipod® 5 since the development from user experience and design to clinical trial site training and support. In part 2 of this fact from fake news episode she will share more details on the Omnipod 5 algorithm known as SmartAdjust™ technology and best practices for everyday use and optimization. Questions covered in this episode:• What are the requirements for entering Automated Mode?• What are the considerations for transitioning from different therapies?• How often should users deliver correction boluses?• What are the adjustable settings for Omnipod 5, and what does and does not impact algorithm behavior?  Please speak with your healthcare team before making any changes to your diabetes management. This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution. **Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information.

Omnipod® 5 Automated Insulin Delivery System: Facts vs. Fake News Part 2

Brought to you by the makers of Omnipod, Beyond the Bolus explores topics beyond the basics of diabetes management and takes a closer look at the treatment and care of diabetes through the unique perspectives and great minds of people within the diabetes community. Hosted by Dena Gottesman MS, RD, CDCES and Nancy Hanna RN, BSN, CDE, this dynamic duo brings forth their passion for serving patients with diabetes and their curiosity to learn to the series. The episodes will include conversations on visions for the future of diabetes care and technology, practical tips for building a care team, compelling clinical data and more!

Brought to you by the makers of Omnipod, Beyond the Bolus explores topics beyond the basics of diabetes management and takes a closer look at the treatment and care of diabetes through the unique perspectives and great minds of people within the diabetes community.Hosted by Dena Gottesman MS, RD, CDCES and Nancy Hanna RN, BSN, CDE, this dynamic duo brings forth their passion for serving patients with diabetes and their curiosity to learn to the series. The episodes will include conversations on visions for the future of diabetes care and technology, practical tips for building a care team, compelling clinical data and more!

hubhopper

Beyond the Bolus

hubhopper